Thomas C. O'Brien, PhD
Thomas C. O'Brien recently retired from a
position as Business Program Manager in DuPont Ventures,
and, with Strategic Business Units (SBU) and DuPont Growth
Platforms. He led equity investment in external start-ups
and the subsequent licensing-in of their technology to
accelerate new business development in SBUs. Previously he
was with DuPont’s New Business Development group with
responsibility for leading external venture teams at
business schools and internal new business growth teams in
the identification and prioritization of new business
opportunities for corporate sponsorship. Concurrently, he
developed futures and ideation processes that were
integrated into corporate business growth and renewal
processes. With New Business Development, Dr. O’Brien also
started new business ventures, provided new business
leadership for DuPont's Fine and Custom Chemicals Venture,
and directed the Microfabrication/ Minichemical Systems
Development Program. Earlier with DuPont's Development
Division, Dr. O'Brien was the Strategist with
responsibilities for market and technology opportunity
assessments, business development, equity options
investments, and technology transfer and out-licensing.
Prior to joining DuPont in 1983, he was a senior technology
analyst in the Department of Commerce and developed the
strategy for NIST's participation in biotechnology. Dr.
O'Brien served as a COMSCI Fellow with the House Science,
Research and Technology Subcommittee in the 96th Congress
chaired by the late George Brown (D-California) with
responsibilities for biotechnology, industrial innovation,
and industry-university-government relations.
At the National Institutes of Health for over a decade, he
held senior health science leadership positions at the
National Eye Institute and National Institute for Dental
Research and virology research and vaccine regulatory
testing positions at the Bureau of Biologics.
Dr. O'Brien is an elected Fellow of the American Association
for the Advancement of Science and an elected member of
AAAS’ Industrial Science and Technology Section Committee.
He served on the Governor's Commission on Science and
Technology for both New Jersey and Delaware. He holds an AB
in Biology and MS and PhD degrees in Microbiology from the
Catholic University of America. Dr. O’Brien is the author of
over 50 publications and reports.
"We are already
looking into using them again."
- President at a biotechnology company.